retatrutide sleep apnea had a new study released yesterday showing its many benefits including dramatic weight loss. There was a blood pressure lowering effect. Over a 70% reduction in arthritis pain. Retatrutide also showed Eli Lilly's newest weight loss

Chronic inflammation can contribute to many health conditions, and obesity is a leading cause of chronic inflammation. Muskiet explained that the GLP-1 therapies may have various effects independent of weight loss

About 36 million American workers have a body mass index (BMI) that would qualify for a GLP-1 prescription

Tirzepatide reaches peak blood concentration around 8 to 12 days after injection, though many patients notice early appetite changes within 3 to 7 days

The reason you see GI side effect is that GLPs slow gastric emptying and change gut motility

The development of diabetes and obesity is underpinned by chronic inflammation [143]